Sign up
Log in
Deals of the day-Mergers and acquisitions
Share
Listen to the news
Deals of the day-Mergers and acquisitions

Adds FEMSA, R1 RCM, Trafigura, Royal Mail, RedBird IMI, Talen Energy, Hewlett Packard Enterprise

- The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday:


** Mexico's FEMSA FEMSAUBD.MX said it has entered into definitive agreements to acquire the retail operations of Delek US Holdings DK.N for $385 million.


** R1 RCM RCM.O said private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would acquire the healthcare technology company in a deal that values it at $8.9 billion.


** Rhone Energies, a consortium of commodity trader Trafigura [RIC:RIC:TRAFGF.UL] and Entara LLC, has agreed with ExxonMobil's ESSO SAF ESSF.PA to buy the Fos-sur-Mer refinery and Toulouse and Villette-de-Vienne terminals in France.


** The British government has called in Czech billionaire Daniel Kretinsky's takeover bid for Royal Mail for closer scrutiny under the National Security and Investment act, the BBC reported.


** Hedge fund tycoon Paul Marshall is closing in on a deal to buy the Spectator magazine from Abu Dhabi-backed RedBird IMI which is selling the title as well as the Telegraph , according to two people with knowledge of the situation.

** Talen Energy TLN.O is looking to sell its stake in a cryptocurrency mining operation powered by its Pennsylvania plant in a process marketed to both data center developers and cryptominers, three sources familiar with the process said.

** The EU Commission said it had unconditionally approved the $14 billion takeover of gear maker Juniper Networks JNPR.N by Hewlett Packard Enterprise HPE.N.


** Cellnex CLNX.MC, Europe's largest mobile phone tower operator, said it was in advanced to sell its Austrian unit after receiving binding offers, triggering a rise in shares.


** Ayala Corp AC.PS, the Philippines' oldest conglomerate, is exploring selling a minority stake in Ayala Healthcare Holdings (AC Health) in a potential deal that could value its healthcare arm at up to $500 million, two people said.


** Japan's Otsuka Pharmaceutical 4578.T said it agreed to pay more than $1 billion to acquire Jnana Therapeutics as it looks to expand its drug pipeline and research base in the Boston area.


** The Australian competition watchdog will oppose Louis Dreyfus' proposal to take over Namoi Cotton NAM.AX, the regulator said, a month after it raised concerns over a similar buyout bid by a Singaporean entity.


** U.S. businessman Elon Musk said his artificial intelligence startup xAI is considering an acquisition of chatbot startup Character.AI, according to a statement on social media website X.


** Australia's Pacific Smiles PSQ.AX recommended that shareholders vote in favour of a sweetened bid of A$327.1 million ($214.05 million) by National Dental Care (NDC) over a competing takeover offer from U.S.-based Genesis Capital.


** Chevron Corp's CVX.N proposed purchase of oil producer Hess HES.N faces a lengthy delay, with an arbitration panel expected to hear a rival's claim to Hess' stake in a Guyana oil-producing joint venture until May 2025, the company said.


** Egyptian microfinance lending and payments company MNT-Halan's recent purchase of Turkey's biggest micro-leasing company will help develop its factoring business in Egypt while expanding consumer credit in Turkey, its chief executive said.


** Italian app developer Bending Spoons has bought file-sharing platform WeTransfer, the companies said in a joint statement, as the Milan-based tech company presses ahead with a string of deals for software firms.


** French retailer Casino CASP.PA longer considers Brazil's GPA PCAR3.SA a strategic holding and is open to selling its remaining 22.5% stake in the company, an executive at Casino's financial communications department said.


** UK's John Wood Group WG.L extended the deadline by which Dubai-based engineering and consulting firm Sidara would to make a firm offer for the company to later than August 9.


(Compiled by Rajarshi Roy and Harshita Mary Varghese in Bengaluru)

((Harshitamary.varghese@thomsonreuters.com))

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.